NCT05485558View on ClinicalTrials.gov

the Safety and Efficacy of N-acetyl Cysteine in Children With Drug-Resistant Epilepsy

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 15, 2022

Primary Completion Date

June 1, 2024

Study Completion Date

January 1, 2025

Conditions
Drug Resistant Epilepsy
Interventions
DRUG

N-acetyl cysteine

10 mg/kg of N-acetyl cysteine capsules together with their standard antiepileptic drug for 6 months.

DRUG

Placebo

15 patients will receive standard antiepileptic drug plus placebo capsules for 6 months.

DRUG

NAc

40 mg/kg of N-acetyl cysteine capsules together with their standard antiepileptic drug for 6 months.

Trial Locations (1)

Unknown

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER